Anti-IL-23 Antibodies
AssigneeJanssen Biotech, Inc.
InventorsJacqueline Benson, Jill Carton, Mark Cunningham, Yevgeniya Orlovsky, Robert Pauchenberger, Raymond Sweet
Life of this patent
Estimating the term…
Abstract
A human anti-IL-23p19 antibody, including isolated nucleic acids that encode at least one anti-IL-23p19 antibody, vectors, host cells, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.
Claims2
An anti-idiotype antibody or fragment that specifically binds an IL-23p19 antibody comprising a light chain variable region and a heavy chain variable region, the light chain variable region comprising a complementarity determining region light chain 1 (CDRL1) amino acid sequence of SEQ ID NO:50, a CDRL2 amino acid sequence of SEQ ID NO:56, and a CDRL3 amino acid sequence of SEQ ID NO:73, the heavy chain variable region comprising a complementarity determining region heavy chain 1 (CDRH1) amino acid sequence of SEQ ID NO:5, a CDRH2 amino acid sequence of SEQ ID NO:20, and a CDRH3 amino acid sequence of SEQ ID NO:44.
An anti-idiotype antibody or fragment that specifically binds an IL-23p19 antibody comprising a light chain variable region amino acid sequence of SEQ ID NO:116 and a heavy chain variable region amino acid sequence of SEQ ID NO:
- 106
Dependencies are inferred from the claim text.